Plasmidsaurus
Private Company
Total funding raised: $2M
Overview
Plasmidsaurus is a disruptive, asset-light sequencing-as-a-service company that has rapidly gained traction by offering exceptionally fast turnaround times and publication-grade accuracy. By leveraging partnerships with leading technology providers like Oxford Nanopore and operating a decentralized network of labs and dropboxes, it provides accessible, hassle-free sequencing to over 70,000 scientists. The company has positioned itself as a critical enabler for R&D across genetics, synthetic biology, and therapeutic development, with a strong focus on customer experience and technical innovation.
Technology Platform
Technology-agnostic sequencing-as-a-service platform leveraging partnerships with leading hardware providers (e.g., Oxford Nanopore) for early access to latest chemistries, combined with a proprietary bioinformatics pipeline and a global network of labs and dropboxes for ultrafast sample processing and data delivery.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Plasmidsaurus competes in the fragmented DNA sequencing services market against large commercial providers (e.g., Azenta/GENEWIZ, QuintaraBio), academic core facilities, and in-house capabilities at pharma companies. Its primary competitive advantages are its exceptional speed, strong focus on user experience, and specialized applications like whole plasmid and AAV sequencing.